India, Aug. 4 -- Telangana Life Sciences, BITS Pilani and RMIT University, Australia, have jointly launched an Industry-Integrated PhD & Research Programme to bridge industry and academia and strength... Read More
India, Aug. 4 -- image credit- freepik A study led by Dr Pawan Kumar and Dr Kapil Singh from the Ministry of Health and Family Welfare, Government of India along with Dr Susmita Chatterjee from The G... Read More
India, Aug. 4 -- What are the major plans in store for the Indian biotech and pharma market at Anton Paar in 2026? As analytical requirements become more sophisticated, our focus is on strengthening ... Read More
India, Aug. 3 -- image credit- freepik Mumbai-based Encube Ethicals has filed its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and Exchange Board of India (SEBI) for... Read More
India, Aug. 3 -- Time Medical International Ventures (India), a wholly owned subsidiary of Fischer Medical Ventures and a global leader in advanced medical imaging solutions, has entered into a partne... Read More
India, Aug. 3 -- Eisai, a leading global research and development-based pharmaceutical company headquartered in Japan, has announced the launch of Leqembi (lecanemab) for the treatment of early Alzhei... Read More
India, Aug. 3 -- The Medical Technology Association of India (MTaI) has called for closer alignment between India's Free Trade Agreement framework and domestic policies governing regulation, procureme... Read More
India, Aug. 1 -- image credit- shutterstock When Sun Pharmaceutical Industries agreed in April 2026 to acquire New Jersey-based Organon & Co. for $11.75 billion - $14.00 a share, all cash - the cover... Read More
India, Aug. 1 -- image credit- freepik The National Pharmaceutical Pricing Authority (NPPA) took an unusual but significant step on June 12, 2026, by increasing the ceiling prices of the chemotherapy... Read More
India, Aug. 1 -- image credit- freepik Drug safety has come under renewed scrutiny as regulators in India and overseas step up surveillance beyond manufacturing compliance. Within weeks, Lupin's reca... Read More